These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 13384740)

  • 21. [Peripheral effect of new urea derivatives with hypoglycemic action].
    CANAL N; GARATTINI S; TESSARI L
    Boll Soc Ital Biol Sper; 1956 Jun; 32(6):491-4. PubMed ID: 13374139
    [No Abstract]   [Full Text] [Related]  

  • 22. The action of a sulfonylurea hypoglycemic agent (orinase) in extrahepatic tissues.
    BRITTON B; GRABOWSKI R; WICK AN
    Metabolism; 1956 Nov; 5(6 Part 2):739-43. PubMed ID: 13378041
    [No Abstract]   [Full Text] [Related]  

  • 23. In vitro studies on the action of sulfonamide hypoglycemic agents.
    VAUGHAN M
    Science; 1956 May; 123(3203):885-6. PubMed ID: 13324105
    [No Abstract]   [Full Text] [Related]  

  • 24. Metabolic effects of arylsulfonylurea compounds in normal men and in diabetic subjects.
    ACKERMAN IP; CONN JW; FAJANS SS; GITTLER RD; HENNES AR; JOHNSON RD; LOUIS LH; SELTZER HS; WAJCHENBERG BL
    Metabolism; 1956 Nov; 5(6 Part 2):820-39. PubMed ID: 13378052
    [No Abstract]   [Full Text] [Related]  

  • 25. Intrapancreatic perfusion of the antidiabetic sulfonylureas.
    COLWELL AR; COLWELL AR; COLWELL JA
    Metabolism; 1956 Nov; 5(6 Part 2):749-56. PubMed ID: 13378043
    [No Abstract]   [Full Text] [Related]  

  • 26. [Experimental studies of a new sulfamide with hypoglycemic action].
    PELLEGRINI R
    Arch Ital Sci Farmacol; 1956 Jul; 6(3):299-304. PubMed ID: 13382497
    [No Abstract]   [Full Text] [Related]  

  • 27. Relation to quantity of sulfonylurea by mouth to the hypoglycemic response in normal human subjects.
    DIENGOTT D; MIRSKY IA
    J Pharmacol Exp Ther; 1956 Oct; 118(2):168-73. PubMed ID: 13368054
    [No Abstract]   [Full Text] [Related]  

  • 28. Effects of tolbutamide and carbutamide on thyroid function.
    BROWN J; SOLOMON DH
    Metabolism; 1956 Nov; 5(6 Part 2):813-9. PubMed ID: 13378051
    [No Abstract]   [Full Text] [Related]  

  • 29. [Hypoglycemic mechanism of action of sulfanylurea; experimental research].
    GRIGNANI F; LARIZZA P
    Minerva Med; 1956 Oct; 47(84 Suppl):1299-322. PubMed ID: 13387270
    [No Abstract]   [Full Text] [Related]  

  • 30. The inhibition of insulinase by hypoglycemic sulfonamides.
    MIRSKY IA; PERISUTTI G; DIENGOTT D
    Metabolism; 1956 Mar; 5(2):156-61. PubMed ID: 13296877
    [No Abstract]   [Full Text] [Related]  

  • 31. [Use & mechanism of action of sulfonamide derivatives decreasing the blood sugar in insulin shock therapy in psychiatry].
    BAYREUTHER H
    Arch Psychiatr Nervenkr Z Gesamte Neurol Psychiatr; 1957; 195(5):435-45. PubMed ID: 13435855
    [No Abstract]   [Full Text] [Related]  

  • 32. Blood glutathione in mild diabetes mellitus before treatment and during sulfonylurea-induced hypoglycemia.
    SELTZER HS
    Proc Soc Exp Biol Med; 1957 May; 95(1):74-6. PubMed ID: 13431994
    [No Abstract]   [Full Text] [Related]  

  • 33. [Morphological findings on the mode of action of oral antidiabetics].
    KRACHT J; VON HOLT C; VON HOLT L
    Endokrinologie; 1957; 34(3):129-46. PubMed ID: 13427715
    [No Abstract]   [Full Text] [Related]  

  • 34. [The antidiabetic action of BZ 55 in clinical experience].
    BELTRAMETTI L; ZAMPORI O
    G Clin Med; 1956 Sep; 37(9):1249-64. PubMed ID: 13384741
    [No Abstract]   [Full Text] [Related]  

  • 35. [Pharmacological action of a new oral antidiabetic drug].
    PELLEGRINI R
    Boll Soc Ital Biol Sper; 1956; 32(1-2):67-9. PubMed ID: 13374024
    [No Abstract]   [Full Text] [Related]  

  • 36. Hypoglycemic effects of 1-butyl-3-p-toluene sulfonylurea given orally in human diabetic subjects; a preliminary report.
    MILLER M; CRAIG JW
    Metabolism; 1956 Mar; 5(2):162-4. PubMed ID: 13296878
    [No Abstract]   [Full Text] [Related]  

  • 37. [Introduction of new peroral hypoglycemic drugs for the ambulant treatment of diabetes mellitus].
    STRATMANN FW
    Medizinische; 1956 Sep; 24(36):1253-7. PubMed ID: 13377930
    [No Abstract]   [Full Text] [Related]  

  • 38. Sulfonylureas and diabetes mellitus. II. Preliminary studies of the mechanism of action.
    COX RW; HENLEY ED; WILLIAMS RH
    Diabetes; 1956; 5(5):366-77. PubMed ID: 13365476
    [No Abstract]   [Full Text] [Related]  

  • 39. Inhibition of glucose-6-phosphatase by hypoglycemic sulfonylureas.
    ASHMORE J; CAHILL GF; HASTINGS AB
    Metabolism; 1956 Nov; 5(6 Part 2):774-7. PubMed ID: 13378046
    [No Abstract]   [Full Text] [Related]  

  • 40. [Problem of the influence of the antidiabetic D 680 on A cells of the islands of Langerhans].
    SCHMID R; BLOBEL R
    Endokrinologie; 1957; 34(3):155-61. PubMed ID: 13427717
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.